Growth Metrics

Cartesian Therapeutics (RNAC) Shares Outstanding (2016)

Historic Shares Outstanding for Cartesian Therapeutics (RNAC) over the last 2 years, with Q2 2016 value amounting to $17.9 million.

  • Cartesian Therapeutics' Shares Outstanding changed N/A to $17.9 million in Q2 2016 from the same period last year, while for Jun 2016 it was $17.9 million, marking a year-over-year change of. This contributed to the annual value of $2.2 million for FY2015, which is N/A changed from last year.
  • Latest data reveals that Cartesian Therapeutics reported Shares Outstanding of $17.9 million as of Q2 2016.
  • Cartesian Therapeutics' 5-year Shares Outstanding high stood at $17.9 million for Q2 2016, and its period low was $2.2 million during Q4 2015.